Filmocid Process Matin
Food supplement declared in France, decision dated 22 October 2026
Filmocid Process Matin, from LAB. O2&VIE SAS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Andrographis paniculata 300 mg per day, Styphnolobium japonicum 107 mg per day, Reynoutria japonica 31 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- LAB. O2&VIE SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- Prendre 2 gélules par jour
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Pregnant women, Taking anticoagulants, Taking diabetes medication, Prolonged use
- Objectives stated by the manufacturer (these are not authorised claims)
- Digestion
Declaration 379995, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Andrographis paniculata (Burm. f.) Nees | Parties aériennes | Extrait sec hydroalcoolique | 300 mg |
| Styphnolobium japonicum (L.) Schott | Feuille | Extrait sec hydroalcoolique | 107 mg |
| Reynoutria japonica Houtt. | Racine | Extrait sec hydroalcoolique | 31 mg |
Additives
E464
Other ingredients
amidon de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne pas utiliser en cas de grossesse. Déconseillé aux femmes allaitantes et aux enfants. Pour les personnes sous traitement antidiabétique ou anticoagulant, ne pas consommer le produit sans avoir pris l'avis au préalable d'un professionnel de santé. L'usage prolongé est déconseillé.
Regulatory points
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Filmocid process matin LAB. O2&VIE SAS, declared in 2025 : different composition: 1 ingredient(s) added, 1 missing
- Filmocid Process Matin LAB. O2&VIE SAS, earlier declaration, replaced by the 2026 declaration : same declared composition
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Filmocid Process Matin: composition and regulation”, https://compoatlas.com/en/supplements/products/379995-filmocid-process-matin, updated 15 November 2026.